The MarketReader Minute
π BioMarin and BridgeBio Report Strong Results; Exact Sciences Faces Setback | Biotech Sector Insights
Among the ETF's holdings, BioMarin Pharmaceutical Inc. reported strong fourth-quarter results, exceeding earnings estimates significantly and raising analysts' price targets. Additionally, the AUD/USD currency pair has increased, reflecting broader market movements that may also influence IBB.